Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

The origins of medulloblastoma subtypes.

Gilbertson RJ, Ellison DW.

Annu Rev Pathol. 2008;3:341-65. Review.

PMID:
18039127
2.

The neurobiology of neurooncology.

Read TA, Hegedus B, Wechsler-Reya R, Gutmann DH.

Ann Neurol. 2006 Jul;60(1):3-11. Review.

PMID:
16802285
3.

The molecular classification of medulloblastoma: driving the next generation clinical trials.

Leary SE, Olson JM.

Curr Opin Pediatr. 2012 Feb;24(1):33-9. doi: 10.1097/MOP.0b013e32834ec106. Review.

4.

Medulloblastoma stem cells: modeling tumor heterogeneity.

Manoranjan B, Venugopal C, McFarlane N, Doble BW, Dunn SE, Scheinemann K, Singh SK.

Cancer Lett. 2013 Sep 10;338(1):23-31. doi: 10.1016/j.canlet.2012.07.010. Review.

PMID:
22796365
5.

Review: personalized mice: modelling the molecular heterogeneity of medulloblastoma.

Markant SL, Wechsler-Reya RJ.

Neuropathol Appl Neurobiol. 2012 Jun;38(3):228-40. doi: 10.1111/j.1365-2990.2011.01235.x. Review.

PMID:
22070547
6.

Only in congenial soil: the microenvironment in brain tumorigenesis.

Rubin JB.

Brain Pathol. 2009 Jan;19(1):144-9. doi: 10.1111/j.1750-3639.2008.00235.x. Review.

PMID:
19076779
7.

Insights into cerebellar development and medulloblastoma.

Bihannic L, Ayrault O.

Bull Cancer. 2016 Jan;103(1):30-40. doi: 10.1016/j.bulcan.2015.11.002. Review.

PMID:
26688373
8.

The clinical implications of medulloblastoma subgroups.

Northcott PA, Korshunov A, Pfister SM, Taylor MD.

Nat Rev Neurol. 2012 May 8;8(6):340-51. doi: 10.1038/nrneurol.2012.78. Review.

PMID:
22565209
9.

Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.

de Haas TG, Kool M.

Clin Neuropathol. 2007 May-Jun;26(3):93-110. Review.

PMID:
19157001
10.

Medulloblastoma.

Bartlett F, Kortmann R, Saran F.

Clin Oncol (R Coll Radiol). 2013 Jan;25(1):36-45. doi: 10.1016/j.clon.2012.09.008. Review.

PMID:
23245832
11.

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.

Huse JT, Holland EC.

Nat Rev Cancer. 2010 May;10(5):319-31. doi: 10.1038/nrc2818. Review.

PMID:
20414201
12.

Pathological and molecular heterogeneity of medulloblastoma.

Gulino A, Arcella A, Giangaspero F.

Curr Opin Oncol. 2008 Nov;20(6):668-75. doi: 10.1097/CCO.0b013e32831369f4. Review.

PMID:
18841049
13.

Modeling medulloblastoma with genetically engineered mice.

Fults DW.

Neurosurg Focus. 2005 Nov 15;19(5):E7. Review.

PMID:
16398471
14.

Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets.

Schmidt AL, Brunetto AL, Schwartsmann G, Roesler R, Abujamra AL.

CNS Neurol Disord Drug Targets. 2010 Jul;9(3):335-48. Review.

PMID:
20438440
16.

In search of the medulloblast: neural stem cells and embryonal brain tumors.

Eberhart CG.

Neurosurg Clin N Am. 2007 Jan;18(1):59-69, viii-ix. Review.

PMID:
17244554
17.

Medulloblastoma stem cells: where development and cancer cross pathways.

Manoranjan B, Venugopal C, McFarlane N, Doble BW, Dunn SE, Scheinemann K, Singh SK.

Pediatr Res. 2012 Apr;71(4 Pt 2):516-22. doi: 10.1038/pr.2011.62. Review.

PMID:
22430388
18.

[WHO classification of brain tumors: present and prospective].

Nakazato Y.

Nihon Rinsho. 2005 Sep;63 Suppl 9:93-8. Review. Japanese. No abstract available.

PMID:
16201506
19.

Analysis of gene expression in the normal and malignant cerebellum.

Wechsler-Reya RJ.

Recent Prog Horm Res. 2003;58:227-48. Review.

PMID:
12795421
20.

Cerebellar granule cells: insights into proliferation, differentiation, and role in medulloblastoma pathogenesis.

Behesti H, Marino S.

Int J Biochem Cell Biol. 2009 Mar;41(3):435-45. doi: 10.1016/j.biocel.2008.06.017. Review.

PMID:
18755286

Supplemental Content

Support Center